715 THREE-YEARS OF CONTINUOUS ENTECAVIR TREATMENT IN CHINESE PATIENTS WHO HAD PREVIOUSLY FAILED LAMIVUDINE: RESULTS FROM STUDIES ETV-056 AND -050
Yao, G.B, Xu, D.Z, Ren, H, Zhou, X.Q, Jia, J.D, Wang, Y.M, Chen, C.W, Liu, J, Xu, D, Llamoso, C
Published in Journal of hepatology (2008)
Published in Journal of hepatology (2008)
Get full text
Journal Article
714 THREE-YEARS OF CONTINUOUS TREATMENT WITH ENTECAVIR RESULTS IN HIGH PROPORTIONS OF CHINESE NUCLEOSIDE-NAIVE PATIENTS WITH UNDETECTABLE HBVDNA: RESULTS FROM STUDIES ETV-023 AND -050
Yao, G.B, Xu, D.Z, Ren, H, Zhou, X.Q, Jia, J.D, Wang, Y.M, Chen, C.W, Liu, J, Xu, D, Llamoso, C
Published in Journal of hepatology (2008)
Published in Journal of hepatology (2008)
Get full text
Journal Article
PP-083 Baseline ALT and HBVDNA levels predict long term therapeutic outcomes in adefovir (ADV) treated Chinese HBeAg(+) chronic hepatitis B (CHB) patients
Zeng, M.D, Mao, Y.M, Yao, G.B, Ren, H, Chen, Y.G, Xu, D.Z, Chen, Y.M
Published in International journal of infectious diseases (2008)
Published in International journal of infectious diseases (2008)
Get full text
Journal Article
Long term safety of lamivudine in asian & Caucasian patients with chronic hepatitis B (CHB)
Leung, N.W.Y., Lai, C.L., Yao, G.B., Marr, C., Chin, J., Atkins, M.
Published in Journal of hepatology (01.04.2001)
Published in Journal of hepatology (01.04.2001)
Get full text
Journal Article